Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report

Utilizing pharmacogenomics (PGx) and integrating drug-induced phenoconversion to guide opioid therapies could improve the treatment response and decrease the occurrence of adverse drug events. Genetics contribute to the interindividual differences in opioid response. The purpose of this case report...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhn, Selina, Amin, Nishita Shah, Bardolia, Chandni, Del Toro-Pagán, Nicole, Pizzolato, Katie, Thacker, David, Turgeon, Jacques, Tomaino, Crystal, Michaud, Veronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225568/
https://www.ncbi.nlm.nih.gov/pubmed/35743759
http://dx.doi.org/10.3390/jpm12060974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225568/
https://www.ncbi.nlm.nih.gov/pubmed/35743759
http://dx.doi.org/10.3390/jpm12060974

Ejemplares similares